Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Identification and characterization of early proteic biomarkers predictive of short term mortality in cancer patients with septic shock.
Study Overview
Brief Summary
The mortality induced by infections in onco-hematological patients is abnormally high at the acute phase of septic shock. Consequently, it is important to detect the population with a high risk of short term mortality among patients with a septic shock. The aim of this study is the evaluation of predictive proteic profile on the short term mortality in the acute phase of septic shock in cancer patients.
Detailed Description
Method: Monocentric prospective study with diagnostic and prognostic expectations.
Primary objective:
Identification and characterization of early proteic biomarkers predictive of short term mortality in cancer patients with septic shock.
Secondary objective:
Research of clinical and biological prognostic factors.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient from oncology or hematology with a septic shock
- •Patient aged 18 years and older
- •Inclusion within the 24 hours of the septic shock in the intensive care unit
- •Signed consent according to the emergency reglementation
Exclusion Criteria
- •Pregnancy, breast feeding
- •Patient with decision of care limitation
- •Patient with legal protection
Outcomes
Primary Outcomes
Identification and characterization of early proteic biomarkers predictive of short term mortality in cancer patients with septic shock.
Time Frame: 1 month
Secondary Outcomes
- Research of clinical and biological prognostic factors.(1 month)